Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emerging targeted combinations in the management of breast cancer.
Lee RJ, Armstrong AC, Wardley AM. Lee RJ, et al. Among authors: wardley am. Breast Cancer (Dove Med Press). 2013 Aug 13;5:61-72. doi: 10.2147/BCTT.S26771. eCollection 2013. Breast Cancer (Dove Med Press). 2013. PMID: 24648759 Free PMC article. Review.
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer.
Board RE, Wardley AM, Dixon JM, Armstrong AC, Howell S, Renshaw L, Donald E, Greystoke A, Ranson M, Hughes A, Dive C. Board RE, et al. Among authors: wardley am. Breast Cancer Res Treat. 2010 Apr;120(2):461-7. doi: 10.1007/s10549-010-0747-9. Epub 2010 Jan 28. Breast Cancer Res Treat. 2010. PMID: 20107891
Letrozole: advancing hormone therapy in breast cancer.
Lee RJ, Armstrong AC, Wardley AM. Lee RJ, et al. Among authors: wardley am. Womens Health (Lond). 2012 Nov;8(6):611-8. doi: 10.2217/whe.12.49. Womens Health (Lond). 2012. PMID: 23181527 Free article.
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.
Earl HM, Hiller L, Dunn JA, Blenkinsop C, Grybowicz L, Vallier AL, Abraham J, Thomas J, Provenzano E, Hughes-Davies L, Gounaris I, McAdam K, Chan S, Ahmad R, Hickish T, Houston S, Rea D, Bartlett J, Caldas C, Cameron DA, Hayward L; ARTemis Investigators. Earl HM, et al. Lancet Oncol. 2015 Jun;16(6):656-66. doi: 10.1016/S1470-2045(15)70137-3. Epub 2015 May 11. Lancet Oncol. 2015. PMID: 25975632 Free article. Clinical Trial.
Patient-derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis.
Eyre R, Alférez DG, Spence K, Kamal M, Shaw FL, Simões BM, Santiago-Gómez A, Sarmiento-Castro A, Bramley M, Absar M, Saad Z, Chatterjee S, Kirwan C, Gandhi A, Armstrong AC, Wardley AM, O'Brien CS, Farnie G, Howell SJ, Clarke RB. Eyre R, et al. Among authors: wardley am. J Mammary Gland Biol Neoplasia. 2016 Dec;21(3-4):99-109. doi: 10.1007/s10911-016-9361-8. Epub 2016 Sep 28. J Mammary Gland Biol Neoplasia. 2016. PMID: 27680982 Free PMC article.
Erratum to: Patient-Derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis.
Eyre R, Alférez DG, Spence K, Kamal M, Shaw FL, Simões BM, Santiago-Gómez A, Sarmiento-Castro A, Bramley M, Absar M, Saad Z, Chatterjee S, Kirwan C, Gandhi A, Armstrong AC, Wardley AM, O'Brien CS, Farnie G, Howell SJ, Clarke RB. Eyre R, et al. Among authors: wardley am. J Mammary Gland Biol Neoplasia. 2016 Dec;21(3-4):111. doi: 10.1007/s10911-016-9364-5. J Mammary Gland Biol Neoplasia. 2016. PMID: 27815673 Free PMC article. No abstract available.
83 results